Literature DB >> 22186626

Structural and functional analysis of the flexible regions of the catalytic α-subunit of protein kinase CK2.

Elena Papinutto1, Alessandro Ranchio, Graziano Lolli, Lorenzo A Pinna, Roberto Battistutta.   

Abstract

CK2 is a Ser/Thr protein kinase essential for cell viability. Its activity is anomalously high in several solid (prostate, mammary gland, lung, kidney and head and neck) and haematological tumours (AML, CML and PML), creating conditions favouring the onset of cancer. Cancer cells become addicted to high levels of CK2 activity and therefore this kinase is a remarkable example of "non-oncogene addiction". CK2 is a validated target for cancer therapy with one inhibitor in phase I clinical trials. Several crystal structures of CK2 are available, many in complex with ATP-competitive inhibitors, showing the presence of regions with remarkable flexibility. We present the structural characterisation of these regions by means of seven new crystal structures, in the apo form and in complex with inhibitors. We confirm previous findings about the unique flexibility of the CK2α catalytic subunit in the hinge/αD region, the p-loop and the β4β5 loop, and show here that there is no clear-cut correlation between the conformations of these flexible zones. Our findings challenge some of the current interpretations on the functional role of these regions and dispute the hypothesis that small ligands stabilize an inactive state. The mobility of the hinge/αD region in the human enzyme is unique among protein kinases, and this can be exploited for the development of more selective ATP-competitive inhibitors. The identification of different ligand binding modes to a secondary site can provide hints for the design of non-ATP-competitive inhibitors targeting the interaction between the α catalytic and the β regulatory subunits. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22186626     DOI: 10.1016/j.jsb.2011.12.007

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  9 in total

1.  Conformational flexibility of human casein kinase catalytic subunit explored by metadynamics.

Authors:  Aurélie Gouron; Anne Milet; Helene Jamet
Journal:  Biophys J       Date:  2014-03-04       Impact factor: 4.033

2.  Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate.

Authors:  Simone Fabbian; Gabriele Giachin; Massimo Bellanda; Christian Borgo; Maria Ruzzene; Giacomo Spuri; Ambra Campofelice; Laura Veneziano; Marcella Bonchio; Mauro Carraro; Roberto Battistutta
Journal:  Front Mol Biosci       Date:  2022-06-02

3.  2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site.

Authors:  Benoît Bestgen; Isabelle Krimm; Irina Kufareva; Ahmed Ashraf Moustafa Kamal; Wei-Guang Seetoh; Chris Abell; Rolf W Hartmann; Ruben Abagyan; Claude Cochet; Marc Le Borgne; Matthias Engel; Thierry Lomberget
Journal:  J Med Chem       Date:  2019-02-18       Impact factor: 7.446

4.  Insights into the Impact of Linker Flexibility and Fragment Ionization on the Design of CK2 Allosteric Inhibitors: Comparative Molecular Dynamics Simulation Studies.

Authors:  Yue Zhou; Na Zhang; Xiaoqian Qi; Shan Tang; Guohui Sun; Lijiao Zhao; Rugang Zhong; Yongzhen Peng
Journal:  Int J Mol Sci       Date:  2018-01-01       Impact factor: 5.923

5.  Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor.

Authors:  Karsten Niefind; Nils Bischoff; Andriy G Golub; Volodymyr G Bdzhola; Anatoliy O Balanda; Andriy O Prykhod'ko; Sergiy M Yarmoluk
Journal:  Pharmaceuticals (Basel)       Date:  2017-01-11

6.  Alternaria toxins as casein kinase 2 inhibitors and possible consequences for estrogenicity: a hybrid in silico/in vitro study.

Authors:  Georg Aichinger; Luca Dellafiora; Foteini Pantazi; Giorgia Del Favero; Gianni Galaverna; Chiara Dall'Asta; Doris Marko
Journal:  Arch Toxicol       Date:  2020-04-23       Impact factor: 5.153

Review 7.  [Protein kinase CK2 and human malignant tumors].

Authors:  Yixuan Huang; Shaohua Zhou; Hongsheng Xue; Zhilong Zhao; Lin Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-07

8.  Exploring the Pivotal Role of the CK2 Hinge Region Sub-Pocket in Binding with Tricyclic Quinolone Analogues by Computational Analysis.

Authors:  Yue Zhou; Na Zhang; Shan Tang; Xiaoqian Qi; Lijiao Zhao; Rugang Zhong; Yongzhen Peng
Journal:  Molecules       Date:  2017-05-19       Impact factor: 4.411

9.  The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation.

Authors:  Giorgio Cozza; Andrea Venerando; Stefania Sarno; Lorenzo A Pinna
Journal:  Biomed Res Int       Date:  2015-10-19       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.